Simvastatin and Edurant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Simvastatin (simvastatin) and Edurant (rilpivirine hydrochloride). Common drug interactions include emotional distress among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Simvastatin and Edurant. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,969 Simvastatin users. Check the latest studies of Simvastatin.

What is Edurant?

Edurant has active ingredients of rilpivirine hydrochloride. eHealthMe is studying from 2,238 Edurant users. Check the latest studies of Edurant.



On Jul, 22, 2026

16 people who take Simvastatin and Edurant together, and have interactions are studied.

Simvastatin and Edurant drug interactions.

What are the common drug interactions of Simvastatin and Edurant, by gender? *:

female:

  1. Emotional distress
  2. Osteoporosis (bones weak and more likely to break)
  3. Pain
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Chronic kidney disease
  7. Anaemia (lack of blood)
  8. Arthralgia (joint pain)
  9. Bone density decreased
  10. Depression

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Proteinuria (presence of protein in the urine)
  4. Quality of life decreased
  5. Renal injury (kidney injury)
  6. Upper limb fracture
  7. Dysgeusia (disorder of the sense of taste)
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Spinal compression fracture (fracture due to spinal compression on bone)

What are the common drug interactions of Simvastatin and Edurant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Decreased activity
  4. Emotional distress
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Pain
  8. Quality of life decreased
  9. Spinal compression fracture (fracture due to spinal compression on bone)
  10. Upper limb fracture

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Renal injury (kidney injury)

60+:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Renal failure (kidney dysfunction)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Anxiety
  6. Blood creatinine increased
  7. Emotional distress
  8. Pain
  9. Proteinuria (presence of protein in the urine)
  10. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. Hiv Infection: 12 people, 75.00%
  2. Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 25.00%
  3. Interstitial Lung Disease: 3 people, 18.75%
  4. High Blood Pressure: 3 people, 18.75%
  5. Pain: 2 people, 12.50%
  6. Prostatic Disorder: 1 person, 6.25%
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 1 person, 6.25%
  8. Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 1 person, 6.25%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
  10. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and Edurant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Simvastatin and Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Simvastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Edurant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin and rilpivirine hydrochloride (the active ingredients of Simvastatin and Edurant, respectively), and Simvastatin and Edurant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: